Pharmacological modulation of nucleic acid sensors—therapeutic potential and persisting obstacles
C Vanpouille-Box, JA Hoffmann… - Nature reviews Drug …, 2019 - nature.com
Nucleic acid sensors, primarily TLR and RLR family members, as well as cGAS–STING
signalling, play a critical role in the preservation of cellular and organismal homeostasis …
signalling, play a critical role in the preservation of cellular and organismal homeostasis …
[HTML][HTML] Immunopathogenesis and therapy of cutaneous T cell lymphoma
EJ Kim, S Hess, SK Richardson… - The Journal of …, 2005 - Am Soc Clin Investig
Cutaneous T cell lymphomas (CTCLs) are a heterogenous group of lymphoproliferative
disorders caused by clonally derived, skin-invasive T cells. Mycosis fungoides (MF) and …
disorders caused by clonally derived, skin-invasive T cells. Mycosis fungoides (MF) and …
Exosome-based tumor antigens–adjuvant co-delivery utilizing genetically engineered tumor cell-derived exosomes with immunostimulatory CpG DNA
M Morishita, Y Takahashi, A Matsumoto, M Nishikawa… - Biomaterials, 2016 - Elsevier
For cancer immunotherapy via tumor antigen vaccination in combination with an adjuvant,
major challenges include the identification of a particular tumor antigen and efficient delivery …
major challenges include the identification of a particular tumor antigen and efficient delivery …
Close encounters of different kinds: dendritic cells and NK cells take centre stage
MA Degli-Esposti, MJ Smyth - Nature Reviews Immunology, 2005 - nature.com
Immune responses are generally divided into innate and adaptive responses, and the
efficacy of one is thought to be independent of the other. The regulation of immune …
efficacy of one is thought to be independent of the other. The regulation of immune …
Plasmacytoid dendritic cells: linking innate and adaptive immunity
K McKenna, AS Beignon, N Bhardwaj - Journal of virology, 2005 - Am Soc Microbiol
Plasmacytoid dendritic cells (pDCs) are one of two principal subsets of human dendritic cells
(DCs). pDCs were initially identified in pathological specimens of reactive or neoplastic …
(DCs). pDCs were initially identified in pathological specimens of reactive or neoplastic …
Development of TLR9 agonists for cancer therapy
AM Krieg - The Journal of clinical investigation, 2007 - Am Soc Clin Investig
In vertebrates, the TLRs are a family of specialized immune receptors that induce protective
immune responses when they detect highly conserved pathogen-expressed molecules …
immune responses when they detect highly conserved pathogen-expressed molecules …
[HTML][HTML] Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without …
PO Ilyinskii, CJ Roy, CP O'Neil, EA Browning, LA Pittet… - Vaccine, 2014 - Elsevier
Augmentation of immunogenicity can be achieved by particulate delivery of an antigen and
by its co-administration with an adjuvant. However, many adjuvants initiate strong systemic …
by its co-administration with an adjuvant. However, many adjuvants initiate strong systemic …
[HTML][HTML] The role of toll-like receptors in the pathogenesis and treatment of dermatological disease
JE McInturff, RL Modlin, J Kim - Journal of Investigative Dermatology, 2005 - Elsevier
Toll-like receptors (TLR) are crucial players in the innate immune response to microbial
invaders. These receptors are expressed on immune cells, such as monocytes …
invaders. These receptors are expressed on immune cells, such as monocytes …
Induction of potent anti-tumor responses while eliminating systemic side effects via liposome-anchored combinatorial immunotherapy
Immunostimulatory therapies that activate immune response pathways are of great interest
for overcoming the immunosuppression present in advanced tumors. Agonistic anti-CD40 …
for overcoming the immunosuppression present in advanced tumors. Agonistic anti-CD40 …
Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotides
AM Krieg - Current oncology reports, 2004 - Springer
Tumor immunotherapy has evolved from the use of crude bacterial extracts to chemically
synthesized ligands for specific immune receptors, such as Toll-like receptors (TLRs). One of …
synthesized ligands for specific immune receptors, such as Toll-like receptors (TLRs). One of …